Moreover, DLD-1 CRC cells treated with different doses of ACM for 8 h further showed that ACM induces the expressions of SREBP-1 mRNA (Figure 2C) and protein (Figure 2D) in the dose-dependent manners compared to the control cells. Here, SREBF1 is linked to colorectal carcinoma.